NOS3 and diabetic kidney disease: Studies have shown that astragaloside IV enhances eNOS expression by activating the adenosine 5′-monophosphate-activated protein kinase (AMPK)/eNOS signaling pathway, improves renal function, and reduces proteinuria in DKD rats induced by a high-fat diet with streptozotocin (STZ) [55].